Clinical Trial Update: Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy [Phase 2]

View source ↗

Summary

Phase 2 compassionate-use update for metreleptin in previously treated people with partial lipodystrophy; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hyperlipidemia
• Lipodystrophy

Drugs mentioned

• Myalept (metreleptin) (metreleptin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes, Lipodystrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING